A new study found that certain types of birth control, such as Depo-Provera and hormonal IUDs, are linked to a risk of benign ...

At a Friday hearing, U.S. District Judge M. Casey Rodgers, of the Northern District of Florida, told lawyers that although there were now 932 lawsuits filed over Depo-Provera, another 9,571 remained ...

U.S. District Judge M. Casey Rodgers of the Northern District of Florida is overseeing more than 400 lawsuits alleging that Depo-Provera, an injectable birth control, has caused non-malignant brain ...

Since the beginning of the year, there has been a rise in the number of lawsuits against pharma giant Pfizer over its injectable contraception, Depo-Provera. Consumers have increasingly joined ...

Christy Bieber has a JD from UCLA School of Law and began her career as a college instructor and textbook author. She has been writing full time for over a decade with a focus on making financial and ...

The label revision follows emerging evidence linking long-term use of Depo-Provera (medroxyprogesterone acetate) to a higher likelihood of developing meningiomas — tumors that, while often benign, can ...

Medroxyprogesterone acetate 150mg/mL; IM inj. Medroxyprogesterone acetate inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation and causes thickening of ...

Nov. 22, 2004 — The U.S. Food and Drug Administration (FDA) and Pfizer have notified healthcare professionals via letter of revisions to the safety labeling for medroxyprogesterone acetate (MPA) ...